RE:I'm thinking
I think the first two items (tour, webinar) will do absolutely nothing. Maybe a short-term bump. the French grant may also give a short-term bump. But essentially they are just fluff.
Revenue from Obagi and maybe an update from Wanbang would be different. These are the two things that I think will move the share price.